A. Scott Anderson - Mar 6, 2023 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Mar 6, 2023
Transactions value $
-$563,160
Form type
4
Date filed
3/8/2023, 11:49 AM
Previous filing
Mar 2, 2023
Next filing
May 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $94K +5K +10.61% $18.80 52.1K Mar 6, 2023 Direct
transaction MMSI Common Stock, No Par Value Options Exercise $344K +10K +19.18% $34.40 62.1K Mar 6, 2023 Direct
transaction MMSI Common Stock, No Par Value Sale -$1M -15K -24.14% $66.74 47.1K Mar 6, 2023 Direct F1
transaction MMSI Common Stock, No Par Value Gift $0 -3K -6.36% $0.00 44.1K Mar 7, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -5K $0.00 $0 Mar 6, 2023 Common Stock $5K $18.80 Direct F2
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -10K -100% $0.00* 0 Mar 6, 2023 Common Stock 10K $34.40 Direct F3
holding MMSI Non-qualified stock options (right to buy) 25K Mar 6, 2023 Common Stock 25K $50.50 Direct F4
holding MMSI Non-qualified stock options (right to buy) 13.8K Mar 6, 2023 Common Stock 13.8K $52.17 Direct F5
holding MMSI Non-qualified stock options (right to buy) 7.5K Mar 6, 2023 Common Stock 7.5K $52.17 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.20 to $67.00 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
F3 Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
F4 Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
F5 Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
F6 Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.